MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Consolidator ... Mass Market Scale-up, Global Reach, Public Capital
1) Consolidators: Life Science & Therapeutics Sector
*Consolidators: Therapeutics Sector
Consolidators: Cancer/Oncology Diagnostics & Treatment Companies
MGI Pharma
Parents
Companies: Acquired_(M&A)
Consolidators: Cancer/Oncology Diagnostics & Treatment Companies
Finance & Acquisitions: Eisai
Children
2007: Japanese drug maker Eisai buys MGI Pharma for $3.9 billion (2007)
Biopharmaceutical company focused in oncology and acute care
Dacogen(R) (decitabine) for Injection for the treatment of myelodysplastic syndromes (MDS)
Gliadel(R) Wafer (polifeprosan 20 with carmustine implant) for the treatment of two types of brain cancer, malignant glioma and
Markets Aloxi(R) (palonosetron hydrochloride) Injection for the prevention of chemotherapy-induced nausea and vomiting (CINV),